the 3 beta-hydroxy-5 alpha-androstane configuration of the identified c19o3-metabolites supports a pathway of prostatic and epididymal testosterone disposition which effects activation by 5 alpha-reductase and inactivation and egress by the coupled 5 alpha-3-oxosteroid reductase/3 beta-hydroxysteroid hydroxylase reactions .
C0033572
prostatic
C0039602
5 alpha-reductase